Unknown

Dataset Information

0

Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.

ABSTRACT: Malaria is a protozoal parasitic disease that is widespread in tropical and subtropical regions of Africa, Asia, and the Americas and causes more than 800,000 deaths per year. The continuing emergence of multidrug-resistant Plasmodium falciparum drives the ongoing need for the development of new and effective antimalarial drugs. Our previous work has explored the preliminary structural optimization of 4(1H)-quinolone ester derivatives, a new series of antimalarials related to the endochins. Herein, we report the lead optimization of 4(1H)-quinolones with a focus on improving both antimalarial potency and bioavailability. These studies led to the development of orally efficacious antimalarials including quinolone analogue 20g, a promising candidate for further optimization.

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC3349818 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Malaria is a protozoal parasitic disease that is widespread in tropical and subtropical regions of Africa, Asia, and the Americas and causes more than 800,000 deaths per year. The continuing emergence of multidrug-resistant Plasmodium falciparum drives the ongoing need for the development of new and effective antimalarial drugs. Our previous work has explored the preliminary structural optimization of 4(1H)-quinolone ester derivatives, a new series of antimalarials related to the endochins. Here  ...[more]

Similar Datasets

Unknown Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
| S-EPMC4234439 | biostudies-literature
Unknown Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors.
| S-EPMC7997574 | biostudies-literature
Unknown Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides.
| S-EPMC3375398 | biostudies-literature
Unknown Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.
| S-EPMC6610884 | biostudies-literature
Unknown Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
| S-EPMC7354843 | biostudies-literature
Unknown Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.
| S-EPMC10081510 | biostudies-literature
Unknown Prodrugs of bisthiazolium salts are orally potent antimalarials.
| S-EPMC523447 | biostudies-literature
Unknown Orally bioavailable potent soluble epoxide hydrolase inhibitors.
| S-EPMC2596069 | biostudies-literature
Unknown ICI 56,780 Optimization: Structure-Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinolones with Antimalarial Activity.
| S-EPMC9233739 | biostudies-literature
Unknown Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors.
| S-EPMC6047033 | biostudies-literature